Annual ROA
-63.10%
-17.14%-37.29%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual return on assets is currently -63.10%, with the most recent change of -17.14% (-37.29%) on 31 December 2022. During the last 3 years, it has risen by +6.22% (+8.97%).ZYNE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-72.62%
-9.83%-15.66%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly return on assets is currently -72.62%, with the most recent change of -9.83% (-15.66%) on 30 June 2023.ZYNE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +9.0% | -76.8% |
| 5 y5 years | -7.8% | -101.2% |
ZYNE ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | +84.4% | +101.2% |
Zynerba Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -72.62%(+15.7%) |
| Mar 2023 | - | -62.79%(+16.2%) |
| Dec 2022 | -63.10%(+37.3%) | -54.05%(+7.4%) |
| Sept 2022 | - | -50.31%(+4.2%) |
| June 2022 | - | -48.30%(+9.7%) |
| Mar 2022 | - | -44.03%(+11.6%) |
| Dec 2021 | -45.96%(-33.7%) | -39.46%(-3.9%) |
| Sept 2021 | - | -41.08%(+0.6%) |
| June 2021 | - | -40.84%(-24.4%) |
| Mar 2021 | - | -54.05%(-17.0%) |
| Dec 2020 | -69.32%(+84.7%) | -65.15%(+2.2%) |
| Sept 2020 | - | -63.77%(+21.7%) |
| June 2020 | - | -52.40%(+28.4%) |
| Mar 2020 | - | -40.82%(+9.4%) |
| Dec 2019 | -37.54%(-35.9%) | -37.31%(+3.4%) |
| Sept 2019 | - | -36.09%(-21.7%) |
| June 2019 | - | -46.10%(-16.0%) |
| Mar 2019 | - | -54.86%(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -58.53%(-3.4%) | -62.09%(+1.0%) |
| Sept 2018 | - | -61.50%(+0.6%) |
| June 2018 | - | -61.12%(+20.7%) |
| Mar 2018 | - | -50.65%(+8.4%) |
| Dec 2017 | -60.62%(+3.9%) | -46.74%(-6.0%) |
| Sept 2017 | - | -49.71%(-4.8%) |
| June 2017 | - | -52.23%(-7.9%) |
| Mar 2017 | - | -56.71%(-7.2%) |
| Dec 2016 | -58.33%(+28.4%) | -61.10%(+12.5%) |
| Sept 2016 | - | -54.30%(-4.6%) |
| June 2016 | - | -56.94%(+11.1%) |
| Mar 2016 | - | -51.26%(-0.2%) |
| Dec 2015 | -45.43%(-46.0%) | -51.38%(+18.4%) |
| Sept 2015 | - | -43.39%(-35.4%) |
| June 2015 | - | -67.21%(+6.5%) |
| Mar 2015 | - | -63.11%(+29.3%) |
| Dec 2014 | -84.13%(+145.9%) | -48.81% |
| Dec 2013 | -34.22% | - |
FAQ
- What is Zynerba Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual return on assets?
The current annual ROA of ZYNE is -63.10%
What is the all time high annual ROA for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual return on assets is -34.22%
What is Zynerba Pharmaceuticals quarterly return on assets?
The current quarterly ROA of ZYNE is -72.62%
What is the all time high quarterly ROA for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly return on assets is -36.09%